X4 Pharmaceuticals Inc. (XFOR)
NASDAQ: XFOR
· Real-Time Price · USD
2.84
-0.30 (-9.55%)
At close: Aug 15, 2025, 3:59 PM
2.80
-1.41%
After-hours: Aug 15, 2025, 07:54 PM EDT
X4 Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -25.74M | 282K | -39.82M | -36.7M | 90.83M | -51.77M | -19.13M | -2.31M | -55.71M | -55.71M | -24.02M | -29.1M | -21.21M | -21.96M | -30.21M | -20.18M | -19.64M | -18.68M |
Depreciation & Amortization | 355K | 476K | 273K | 267K | 194K | 62K | 62K | 104K | 126K | 126K | 127K | 124K | 132K | 133K | 132K | 132K | 129K | 106K |
Stock-Based Compensation | 748K | 519K | 2.22M | 1.82M | 2.43M | 1.74M | 2.54M | 2.36M | 2.14M | 1.65M | 1.11M | 1.11M | 1.52M | 1.46M | 1.61M | 1.52M | 1.8M | 1.26M |
Other Working Capital | -48K | -6.04M | 1.49M | -1.27M | 2M | 2.09M | -6.17M | 299K | 2.65M | 2.65M | 1.71M | 1.57M | 583K | 413K | -3.19M | 3.6M | -1.38M | -1.7M |
Other Non-Cash Items | -1.05M | -10.37M | 3.14M | 3.71M | -124.78M | 14.28M | -4M | 636K | 32.74M | 32.74M | -4.88M | 3.31M | 393K | 444K | 615K | 816K | 3.75M | 591K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -1.85M | -25.16M | -2.27M | -2.27M | n/a | n/a | n/a | n/a | 10.12M | n/a | -3.29M | n/a |
Change in Working Capital | -4.21M | -3.28M | 1.2M | -3.14M | 1.05M | 2.09M | -5.36M | 3.54M | 1.55M | 1.55M | 616K | 5.47M | 691K | -300K | -1.33M | 3.5M | -1.95M | -1.72M |
Operating Cash Flow | -29.9M | -12.37M | -32.99M | -34.03M | -30.28M | -33.6M | -27.75M | -20.83M | -21.43M | -21.43M | -26.51M | -19.09M | -18.47M | -20.23M | -19.05M | -14.21M | -19.2M | -18.44M |
Capital Expenditures | n/a | -3M | -41K | -92K | -134K | -59K | -35K | -8K | -8K | -8K | -9K | -34K | -38K | -22K | -13K | -20K | -86K | -496K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 4.8K | -1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -5.07M | -11.89M | -22.78M | -21.09M | -3M | -10.26M | -5.8M | -6.15M | -4.88M | n/a | -4.8M | -4.8M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 28.18M | 11.75M | 14.2M | 5.25M | 2M | 5M | 1M | 1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 98M | n/a | -4.8K | 1M | -4.88K | -4.88M | 4.8M | 4.8M | n/a | -22K | n/a | n/a | n/a | -496K |
Investing Cash Flow | 23.11M | -3.14M | -8.62M | -15.93M | 96.86M | -5.32M | -4.83M | -5.16M | -4.88M | -4.88M | -9K | -34K | -38K | -22K | -13K | -20K | -86K | -496K |
Debt Repayment | n/a | n/a | -20M | n/a | 20M | n/a | n/a | 21.74M | 381K | -1.68M | n/a | 439K | -325K | -909K | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 46K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 443K | -443K | n/a | n/a | n/a | n/a | n/a | -4.44K | -924 | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 20.29M | -159K | n/a | n/a | n/a | n/a | 8.23M | n/a | n/a | n/a | n/a | -12K | 103K | n/a | 116K | 41K |
Financial Cash Flow | 5.63M | n/a | 135K | n/a | 20.16M | n/a | 97K | 21.2M | 69.34M | 69.34M | -2.12M | 60.64M | -347K | 4.96M | 24.57M | -4.44M | -924K | 55.04M |
Net Cash Flow | -1.02M | -15.43M | -41.73M | -49.8M | 86.72M | -38.97M | -32.37M | -4.85M | 43.02M | 43.02M | -28.59M | 41.88M | -19.06M | -15.36M | 5.39M | -18.77M | -20.17M | 35.96M |
Free Cash Flow | -29.9M | -15.37M | -33.04M | -34.12M | -30.41M | -33.66M | -27.78M | -20.84M | -21.43M | -21.43M | -26.52M | -19.13M | -18.51M | -20.25M | -19.07M | -14.23M | -19.28M | -18.94M |